GASTER Side Effects

6305170-6 | Cholecystitis Acute, Cholelithiasis
on Jul 31, 2009 Male patient from JAPAN , weighting 187.4 lb, was diagnosed with hypertension, cerebrovascular disorder and was treated with Gaster (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis acute, cholelithiasis. Gaster dosage: 20 Mg. During the same period patient was treated with DIOVAN (80 Mg) (View Diovan Review and Diovan Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ), NORVASC (2.5 Mg) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6179747-5 | Cholecystitis Acute, Cholelithiasis
Patient was taking Gaster (View Usage). Patient had the following side effects: cholecystitis acute, cholelithiasis on Apr 07, 2009 from JAPAN Additional patient health information: Male patient , weighting 187.4 lb, was diagnosed with hypertension, cerebrovascular disorder and. Gaster dosage: 20 Mg. During the same period patient was treated with DIOVAN (80 Mg) (View Diovan Review and Diovan Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6159342-4 | Cholecystitis Acute, Cholelithiasis
Adverse event was reported on Apr 07, 2009 by a Male patient taking Gaster (View Usage) (Dosage: 20 Mg) was diagnosed with hypertension, cerebrovascular disorder and. Location: JAPAN , weighting 187.4 lb, After Gaster was administered, patient had the following side effects: cholecystitis acute, cholelithiasis. During the same period patient was treated with DIOVAN (80 Mg) (View Diovan Review and Diovan Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6052017-1 | Cholecystitis Acute, Cholelithiasis
on Jan 14, 2009 Male patient from , weighting 187.4 lb, was diagnosed with hypertension, cerebrovascular disorder and was treated with Gaster (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis acute, cholelithiasis. Gaster dosage: 20 Mg. During the same period patient was treated with DIOVAN (80 Mg) (View Diovan Review and Diovan Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.


6034747-0 | Cardiac Arrest, Mydriasis
on Jan 07, 2009 Male patient from JAPAN , weighting 145.7 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, angina unstable and was treated with Gaster (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), mydriasis. Gaster dosage: 20 Mg. During the same period patient was treated with NORVASC (5 Mg) (View Norvasc Review and Norvasc Label ), HEPARIN (10000 Unit) (View Heparin Review and Heparin Label ), ASPIRIN (200 Mg) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (Starting Dose 300 Mg) (View Clopidogrel Review and Clopidogrel Label ).

5357246-8 | Anaemia, Platelet Count Decreased
Patient was taking Gaster (View Usage). After Gaster was administered, patient had the following side effects: anaemia, platelet count decreased on Jun 06, 2007 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 149.9 lb, was diagnosed with prophylaxis, peritoneal mesothelioma malignant and. Gaster dosage: 40 Mg, Daily (1/d). During the same period patient was treated with GASMOTIN (15 Mg, Daily (1/d)) (View Gasmotin Review and Gasmotin Label ), MAGNESIUM OXIDE (1.2 G, Daily (1/d)) (View Magnesium Oxide Review and Magnesium Oxide Label ), PEMETREXED (850 Mg, Other) (View Pemetrexed Review and Pemetrexed Label ), CISPLATIN (75 Mg/m2, Other) (View Cisplatin Review and Cisplatin Label ), PANVITAN (0.5 Mg, Daily (1/d)) (View Panvitan Review and Panvitan Label ), CYANOCOBALAMIN (1 Mg, Other) (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5332582-X | Gamma-glutamyltransferase Increased, Haemoglobin Decreased, Platelet Count Decreased
Adverse event was reported on May 08, 2007 by a Male patient taking Gaster (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with prophylaxis, pleural mesothelioma malignant and. Location: JAPAN , 67 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: gamma-glutamyltransferase increased, haemoglobin decreased, platelet count decreased. During the same period patient was treated with GASMOTIN (15 Mg, Daily (1/d)) (View Gasmotin Review and Gasmotin Label ), MAGNESIUM OXIDE (1.2 G, Daily (1/d)) (View Magnesium Oxide Review and Magnesium Oxide Label ), PEMETREXED (850 Mg, Other) (View Pemetrexed Review and Pemetrexed Label ), CISPLATIN (75 Mg/m2, Other) (View Cisplatin Review and Cisplatin Label ), PANVITAN (0.5 Mg, Daily (1/d)) (View Panvitan Review and Panvitan Label ), CYANOCOBALAMIN (1 Mg, Other) (View Cyanocobalamin Review and Cyanocobalamin Label ).

5298155-2 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Diarrhoea, Enanthema, Erythema, Gamma-glutamyltransferase Increased, Mucosal Erosion
on Apr 10, 2007 Female patient from JAPAN , 51 years of age, weighting 198.4 lb, was diagnosed with depression (What is depression?) and was treated with Gaster (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, enanthema, erythema, gamma-glutamyltransferase increased, mucosal erosion. Gaster dosage: . During the same period patient was treated with ASTOMIN (View Astomin Review and Astomin Label ), ALINAMIN (View Alinamin Review and Alinamin Label ), URSO (View Urso Review and Urso Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), CALBLOCK (View Calblock Review and Calblock Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), TEGRETOL (100 Mg/day) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5195231-X | Anti-hbc Antibody Positive, Condition Aggravated, Glaucomatous Optic Disc Atrophy, Hepatic Function Abnormal, Hepatocellular Damage, Liver Disorder, Optic Neuritis Retrobulbar
on Apr 19, 2006 Female patient from JAPAN , 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and was treated with Gaster (View Usage). After Gaster was administered, patient had the following side effects: anti-hbc antibody positive, condition aggravated, glaucomatous optic disc atrophy, hepatic function abnormal, hepatocellular damage, liver disorder, optic neuritis retrobulbar. Gaster dosage: . During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5191401-5 | Hepatic Function Abnormal
Patient was taking Gaster (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Apr 19, 2006 from JAPAN Additional patient health information: Female patient , 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and. Gaster dosage: . During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5163084-1 | Alanine Aminotransferase Increased, Anti-hbc Antibody Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Dizziness, Headache, Hepatic Function Abnormal, Liver Disorder
Adverse event was reported on Apr 19, 2006 by a Female patient taking Gaster (View Usage) (Dosage: ) was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and. Location: JAPAN , 55 years of age, weighting 132.3 lb, Patient had the following side effects: alanine aminotransferase increased, anti-hbc antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dizziness (What is dizziness?), headache (What is headache?), hepatic function abnormal, liver disorder. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5065841-9 | Abdominal Pain, Abscess Drainage, Anorexia, Back Pain, Bile Duct Obstruction, Bile Duct Stone, Biliary Dilatation, Biliary Drainage, Infection
on Sep 16, 2004 Male patient from JAPAN , 35 years of age, weighting 121.3 lb, was diagnosed with gastritis, gastrointestinal stromal tumour, diarrhoea and was treated with Gaster (View Usage). After Gaster was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), abscess drainage, anorexia, back pain (What is back pain?), bile duct obstruction, bile duct stone, biliary dilatation, biliary drainage, infection (What is infection?). Gaster dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg, Bid) (View Gleevec Review and Gleevec Label ), LOPEMIN (View Lopemin Review and Lopemin Label ). Patient was hospitalized.

5034641-8 | Hepatic Function Abnormal
on Apr 19, 2006 Female patient from JAPAN , 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and was treated with Gaster (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Gaster dosage: . During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5029961-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Hepatic Function Abnormal, Visual Acuity Reduced
Patient was taking Gaster (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, visual acuity reduced on Apr 19, 2006 from JAPAN Additional patient health information: Female patient , 55 years of age, weighting 132.3 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and. Gaster dosage: . During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5019088-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Visual Acuity Reduced
Adverse event was reported on Apr 19, 2006 by a Female patient taking Gaster (View Usage) (Dosage: ) was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis prophylaxis, optic neuritis and. Location: JAPAN , 55 years of age, weighting 132.3 lb, After Gaster was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, visual acuity reduced. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

4869208-5 | Idiopathic Thrombocytopenic Purpura, Platelet Count Decreased
on Dec 16, 2005 Male patient from JAPAN , 65 years of age, was treated with Gaster (View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura, platelet count decreased. Gaster dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ).

4778750-7 | Abdominal Pain, Abscess Drainage, Anorexia, Back Pain, Bile Duct Obstruction, Bile Duct Stone, Biliary Dilatation, Biliary Drainage, Infection
on Sep 16, 2004 Male patient from JAPAN , 35 years of age, weighting 121.3 lb, was diagnosed with gastritis, gastrointestinal stromal tumour, diarrhoea and was treated with Gaster (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abscess drainage, anorexia, back pain (What is back pain?), bile duct obstruction, bile duct stone, biliary dilatation, biliary drainage, infection (What is infection?). Gaster dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg, Bid) (View Gleevec Review and Gleevec Label ), LOPEMIN (View Lopemin Review and Lopemin Label ). Patient was hospitalized.

4707995-7 | Aseptic Necrosis Bone, Dental Caries, Dental Treatment, Malignant Neoplasm Progression, Multiple Myeloma, Ostectomy
Patient was taking Gaster (View Usage). After Gaster was administered, patient had the following side effects: aseptic necrosis bone, dental caries, dental treatment, malignant neoplasm progression, multiple myeloma (What is multiple myeloma?), ostectomy on Jun 22, 2005 from JAPAN Additional patient health information: Male patient , 81 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Gaster dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AREDIA (45 Mg, Qmo) (View Aredia Review and Aredia Label ). Patient was hospitalized.

4702216-3 | Aseptic Necrosis Bone, Dental Treatment, Malignant Neoplasm Progression, Ostectomy
Adverse event was reported on Jun 22, 2005 by a Male patient taking Gaster (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: , 81 years of age, Patient experienced the following unwanted or unexpected effects: aseptic necrosis bone, dental treatment, malignant neoplasm progression, ostectomy. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AREDIA (45 Mg, Qmo) (View Aredia Review and Aredia Label ). Patient was hospitalized.

4682459-8 | Abdominal Pain, Abscess Drainage, Anorexia, Back Pain, Bile Duct Obstruction, Bile Duct Stone, Biliary Dilatation, Biliary Drainage, Infection
on Sep 16, 2004 Male patient from , 35 years of age, weighting 121.3 lb, was diagnosed with gastritis, gastrointestinal stromal tumour, diarrhoea and was treated with Gaster (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abscess drainage, anorexia, back pain (What is back pain?), bile duct obstruction, bile duct stone, biliary dilatation, biliary drainage, infection (What is infection?). Gaster dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg, Bid) (View Gleevec Review and Gleevec Label ), LOPEMIN (View Lopemin Review and Lopemin Label ). Patient was hospitalized.